Molecular bio-dosimetry for carcinogenic risk assessment in survivors of Bhopal gas tragedy

International Journal of Occupational Medicine and Environmental Health

Volumn 28, Issue 6, 2015, Pages 921-939

  Mishra, Pradyumna Kumar ^a,b,c   Raghuram, Gorantla Venkata ^a,b,c   Bunkar, Neha ^a   Bhargava, Arpit ^a,b,c   Khare, Naveen Kumar ^b,c  

^a DR H S GOUR UNIVERSITY   (India)

^b TATA MEMORIAL HOSPITAL   (India)

^c BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Biomarkers; Cancer risk; Environmental medicine; Methyl isocyanate; Occupational health; Translational oncology

Indexed keywords

ANTISICKLING AGENT; CARCINOGEN; ISOCYANIC ACID DERIVATIVE; METHYL ISOCYANATE;

BHOPAL DISASTER; CHEMICALLY INDUCED; DISASTER; HUMAN; INCIDENCE; INDIA; NEOPLASMS; RADIOMETRY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; SURVIVOR; TRENDS;

ANTISICKLING AGENTS; BHOPAL ACCIDENTAL RELEASE; CARCINOGENS; DISASTERS; HUMANS; INCIDENCE; INDIA; ISOCYANATES; NEOPLASMS; RADIOMETRY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVORS;

EID: 84951940407     PISSN: 12321087     EISSN: 1896494X     Source Type: Journal    
DOI: 10.13075/ijomeh.1896.00313     Document Type: Review

References (80)

1. Knol AB, Petersen AC, Van Der Sluijs JP, Lebret E. Dealing with uncertainties in environmental burden of disease assessment. Environ Health. 2009;28(8):21, http://dx.doi.org/10.1186/1476-069X-8-21.
2. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825-33, http://dx.doi.org/10.1038/sj.bjc.6602769.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917, http://dx.doi.org/10.1002/ijc.25516.
4. Severson PL, Tokar EJ, Vrba L, Waalkes MP, Futscher BW. Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation. Epigenetics. 2013;8(10):1080-8, http://dx.doi.org/10.4161/epi.25926.
5. Mishra PK, Samarth RM, Pathak N, Jain SK, Banerjee S, Maudar KK. Bhopal gas tragedy: Review of clinical and experimental findings after 25 years. Int J Occup Med Environ Health. 2009;22(3):193-202, http://dx.doi.org/10.2478/v10001-009-0028-1.
6. Mishra PK. A pragmatic and translational approach of human biomonitoring to methyl isocyanate exposure in Bhopal. Indian J Med Res. 2012;135(4):479-84.
7. Letašiová S, Medvedová A, Šovèíková A, Dušinská M, Volkovová K, Mosoiu C, et al. Bladder cancer, a review of the environmental risk factors. Environ Health. 2012;11 Suppl 1:S11, http://dx.doi.org/10.1186/1476-069X-11-S1-S11.
8. Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Ann Rev Public Health. 2013;34:205-16, http://dx.doi.org/10.1146/annurevpublhealth-031811-124704.
9. Pérez-Losada J, Castellanos-Martín A, Mao JH. Cancer evolution and individual susceptibility. Integr Biol (Camb). 2011;3(4):316-28, http://dx.doi.org/10.1039/c0ib00094a.
10. Chiu WA, Euling SY, Scott CS, Subramaniam RP. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era. Toxicol Appl Pharmacol. 2013;271(3):309-23, http://dx.doi.org/10.1016/j.taap. 2010.03.019.
11. Mishra PK, Raghuram GV, Bhargava A, Pathak N. Translation research in molecular disease diagnosis: Bridging gap from laboratory to practice. J Glob Infect Dis. 2011;3(2):205-6, http://dx.doi.org/10.4103/0974-777X.81705.
12. Rozman KK, Doull J, Hayes WJ Jr. Dose and time determining, and other factors influencing, toxicity. In: Krieger R, editor. Hayes' handbook of pesticide toxicology. 3rd ed. New York: Academic Press; 2010. p. 3-101, http://dx.doi.org/10.1016/B978-0-12-374367-1.00001-X.
13. Covaci A, Voorspoels S, Schepens P, Jorens P, Blust R, Neels H. The Belgian PCB/dioxin crisis - 8 years later: An overview. Environ Toxicol Pharmacol. 2008;25(2):164-70, http://dx.doi.org/10.1016/j.etap. 2007.10.003.
14. Bertazzi PA, editor. Disasters, natural and technological. In: Stellman JM, editor-in-chief. Encyclopedia of Occupational Health and Safety. Geneva: International Labor Organization; 2011.
15. Sabbioni G, Wesp H, Lewalter J, Rumler R. Determination of isocyanate biomarkers in construction site workers. Biomarkers. 2007;12(5):468-83, http://dx.doi.org/10.1080/13547500701395636.
16. Beyerbach A, Farmer PB, Sabbioni G. Biomarkers for isocyanate exposure: Synthesis of isocyanate DNA adducts. Chem Res Toxicol. 2006;19(12):1611-8, http://dx.doi.org/10. 1021/tx0600853.
17. Kimmerle G, Eben A. [On the toxicity of methylisocyanate and its quantitative determination in the air]. Arch Toxicol. 1964;20:235-41. German.
18. Klaassen CD. Casarett and Doull's toxicology: The basic science of poisons. 6th ed. New York (NY): McGraw-Hill; 2001. p. 1007.
19. Indian Council of Medical Research. Report on health effects of the toxic gas leak from the methyl isocyanate plant in Bhopal. New Delhi: The Council; 2004.
20. Broughton E. The Bhopal disaster and its aftermath: A review. Environ Health. 2005;4(1):6, http://dx.doi.org/10.1186/1476-069X-4-6.
21. Moore MM, Chua W, Charles KA, Clarke SJ. Inflammation and cancer: Causes and consequences. Clin Pharmacol Ther. 2010;87(4):504-8, http://dx.doi.org/10.1038/clpt.2009.254.
22. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med. 2010;10(4):369-73, http://dx.doi.org/10.2174/156652410791316968.
23. Khan S, Bhargava A, Pathak N, Maudar KK, Varshney S, Mishra PK. Circulating biomarkers and their possible role in pathogenesis of chronic hepatitis B and C viral infections. Indian J Clin Biochem. 2011;26(2):161-8, http://dx.doi.org/10.1007/s12291-010-0098-7.
24. Mishra PK, Panwar H, Bhargava A, Gorantla VR, Jain SK, Banerjee S, et al. Isocyanates induce DNA damage, apoptosis, oxidative stress and inflammation in cultured human lymphocytes. J Biochem Mol Toxicol. 2008;22(6):429-40, http://dx.doi.org/10.1002/jbt.20260.
25. Mishra PK, Bhargava A, Raghuram GV, Gupta S, Tiwari S, Upadhyaya R, et al. Inflammatory response to isocyanates and onset of genomic instability in cultured human lung fibroblasts. Genet Mol Res. 2009;8(1):129-43, http://dx.doi.org/10.4238/vol8-1gmr544.
26. Mishra PK, Bhargava A, Raghuram GV, Jatawa SK, Akhtar N, Khan S, et al. Induction of genomic instability in cultured human colon epithelial cells following exposure to isocyanates. Cell Biol Int. 2009;33(6):675-83, http://dx.doi.org/10.1016/j.cellbi.2009.03.008.
27. Mishra PK, Khan S, Bhargava A, Panwar H, Banerjee S, Jain SK, et al. Regulation of isocyanate-induced apoptosis, oxidative stress, and inflammation in cultured human neutrophils: Isocyanate-induced neutrophils apoptosis. Cell Biol Toxicol. 2010;26(3):279-91, http://dx.doi.org/10.1007/s10565-009-9127-9.
28. Bhargava A, Punde RP, Pathak N, Dabadghao S, Desikan P, Jain A, et al. Status of inflammatory biomarkers in the population that survived the Bhopal gas tragedy: A study after 2 decades. Ind Health. 2010;48(2):204-8, http://dx.doi.org/10.2486/indhealth.48.204.
29. López-Armada MJ, Riveiro-Naveira RR, Vaamonde-García C, Valcárcel-Ares MN. Mitochondrial dysfunction and the inflammatory response. Mitochondrion. 2013;13(2):106-18, http://dx.doi.org/10.1016/j.mito.2013.01.003.
30. Khan S, Raghuram GV, Bhargava A, Pathak N, Chandra DH, Jain SK, et al. Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Transl Res. 2011;158(6):344-59, http://dx.doi.org/10.1016/j.trsl.2011.08.007.
31. Bhargava A, Raghuram GV, Pathak N, Varshney S, Jatawa SK, Jain D, et al. Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic Biol Med. 2011;51(9):1806-14, http://dx.doi.org/10.1016/j.freeradbiomed. 2011.08.009.
32. Bhargava A, Khan S, Panwar H, Pathak N, Punde RP, Varshney S, et al. Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes. Virus Res. 2010;153(1):143-50, http://dx.doi.org/10.1016/j.virusres.2010.07.023.
33. Khan S, Raghuram GV, Pathak N, Jain SK, Chandra DH, Mishra PK. Impairment of mitochondrial-nuclear cross talk in neutrophils of patients with type 2 diabetes mellitus. Indian J Clin Biochem. 2014;29(1):38-44, http://dx.doi.org/10.1007/s12291-013-0321-4.
34. Mishra PK, Raghuram GV, Panwar H, Jain D, Pandey H, Maudar KK. Mitochondrial oxidative stress elicits chromosomal instability after exposure to isocyanates in human kidney epithelial cells. Free Radic Res. 2009;43(8):718-28, http://dx.doi.org/10.1080/10715760903037699.
35. Raghuram GV, Pathak N, Jain D, Pandey H, Panwar H, Jain K, et al. Molecular characterization of isocyanate-induced male germ line genomic instability. J Environ Pathol Toxicol Oncol. 2010;29(3):213-34, http://dx.doi.org/10.1615/JEnvironPatholToxicolOncol.v29.i3.50.
36. Panwar H, Jain D, Khan S, Pathak N, Raghuram GV, Bhargava A, et al. Imbalance of mitochondrial-nuclear cross talk in isocyanate mediated pulmonary endothelial cell dysfunction. Redox Biol. 2013;1(1):163-71, http://dx.doi.org/10.1016/j.redox.2013.01.009.
37. Jantzen K, Roursgaard M, Desler C, Loft S, Rasmussen LJ, Møller P. Oxidative damage to DNA by diesel exhaust particle exposure in co-cultures of human lung epithelial cells and macrophages. Mutagenesis. 2012;27(6):693-701, http://dx.doi.org/10.1093/mutage/ges035.
38. Jain D, Pathak N, Khan S, Raghuram GV, Bhargava A, Samarth R, et al. Evaluation of cytotoxicity and anticarcinogenic potential of Mentha leaf extracts. Int J Toxicol. 2011;30(2):225-36, http://dx.doi.org/10.1177/109158181 0390527.
39. Mishra PK, Raghuram GV, Bhargava A, Ahirwar A, Samarth R, Upadhyaya R, et al. In vitro and in vivo evaluation of the anticarcinogenic and cancer chemopreventive potential of a flavonoid-rich fraction from a traditional Indian herb Selaginella bryopteris. Br J Nutr. 2011;106(8):1154-68, http://dx.doi.org/10.1017/S0007114511001498.
40. Pathak N, Khan S, Bhargava A, Raghuram GV, Jain D, Panwar H, et al. Cancer chemopreventive effects of the flavonoidrich fraction isolated from papaya seeds. Nutr Cancer. 2014;66(5):857-71, http://dx.doi.org/10.1080/01635581. 2014.904912.
41. Durovic B, Spasic-Jokic V, Durovic B. Influence of occupational exposure to low-dose ionizing radiation on the plasma activity of superoxide dismutase and glutathione level. Vojnosanit Pregl. 2008;65(8):613-8, http://dx.doi.org/10.2298/VSP0808613D.
42. Gerberick GF, Aleksic M, Basketter DA, Schultz TW. Chemical reactivity measurement and the predictive identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern Lab Anim. 2008;36(2):215-42.
43. Miyata K, Kobori A, Seio K, Sekine M. Hybridization ability and base pair geometry of modified deoxycytidine derivatives having a 4-N-carbamoyl group. Nucleic Acids Res. 2002;(2):161-2, http://dx.doi.org/10.1093/nass/2.1.161.
44. Mishra PK, Gorantla VR, Akhtar N, Tamrakar P, Jain SK, Maudar KK. Analysis of cellular response to isocyanate using N-succinimidyl N-methylcarbamate exposure in cultured mammalian cells. Environ Mol Mutagen. 2009;50(4):328-36, http://dx.doi.org/10.1002/em.20469.
45. Bartek J, Lukas J. DNA damage checkpoints: From initiation to recovery or adaptation. Curr Opin Cell Biol. 2007;19(2):238-45, http://dx.doi.org/10.1016/j.ceb. 2007.02.009.
46. Panwar H, Raghuram GV, Jain D, Ahirwar AK, Khan S, Jain SK, et al. Cell cycle deregulation by methyl isocyanate: Implications in liver carcinogenesis. Environ Toxicol. 2014;29(3):284-97, http://dx.doi.org/10.1002/tox.21757.
47. Raghuram GV, Pathak N, Jain D, Panwar H, Pandey H, Jain SK, et al. Molecular mechanisms of isocyanate induced oncogenic transformation in ovarian epithelial cells. Reprod Toxicol. 2010;30(3):377-86, http://dx.doi.org/10.1016/j.repro tox.2010.05.087.
48. Delia D, Fontanella E, Ferrario C, Chessa L, Mizutani S. DNA damage-induced cell-cycle phase regulation of p53 and p21waf1 in normal and ATM-defective cells. Oncogene. 2003;22(49):7866-9, http://dx.doi.org/10.1038/sj.onc.1207086.
49. Rizzolio F, Tuccinardi T, Caligiuri I, Lucchetti C, Giordano A. CDK inhibitors: From the bench to clinical trials. Curr Drug Targets. 2010;11(3):279-90, http://dx.doi.org/10.2174/138945010790711978.
50. Nojima H. G1 and S-phase checkpoints, chromosome instability, and cancer. Methods Mol Biol. 2004;280:3-49, http://dx.doi.org/10.1385/1-59259-788-2:003.
51. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential apoptotic signaling. J Biol Chem. 2000;275(21):16202-12, http://dx.doi.org/10.1074/jbc.275.21.16202.
52. Mishra PK, Jatawa SK, Raghuram GV, Pathak N, Jain A, Tiwari A, et al. Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas. Genet Mol Res. 2009;8(4):1202-10, http://dx.doi.org/10.4238/vol8-4gmr653.
53. Mishra PK, Raghuram GV, Jatawa SK, Bhargava A, Varshney S. Frequency of genetic alterations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma: A translational perspective. Asian Pac J Cancer Prev. 2011;12(2):573-4.
54. Vader G, Lens SM. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta. 2008;1786(1):60-72, http://dx.doi.org/10.1016/j.bbcan. 2008.07.003.
55. Ferguson RL, Maller JL. Centrosomal localization of cyclin E-CDK2 is required for initiation of DNA synthesis. Curr Biol. 2010;20(9):856-60, http://dx.doi.org/10.1016/j.cub.2010.03.028.
56. Pacchierotti F, Eichenlaub-Ritter U. Environmental hazard in the aetiology of somatic and germ cell aneuploidy. Cytogenet Genome Res. 2011;133(2-4):254-68, http://dx.doi.org/10.1159/000323284.
57. Potapova TA, Zhu J, Li R. Aneuploidy and chromosomal instability: A vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev. 2013;32(3-4):377-89, http://dx.doi.org/10.1007/s10555-013-9436-6.
58. Tseng RC, Hsieh FJ, Hsu HS, Wang YC. Minimal deletion regions in lung squamous cell carcinoma: Association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers. Lung Cancer. 2008;59(3):332-9, http://dx.doi.org/10.1016/j.lungcan. 2007.08.038.
59. Lu T, Finkel T. Free radicals and senescence. Exp Cell Res. 2008;314(9):1918-22, http://dx.doi.org/10.1016/j.yexcr. 2008.01.011.
60. Mirzayans R, Scott A, Andrais B, Pollock S, Murray D. Ultraviolet light exposure triggers nuclear accumulation of p21 (WAF1) and accelerated senescence in human normal and nucleotide excision repair-deficient fibroblast strains. J Cell Physiol. 2008;215(1):55-67, http://dx.doi.org/10.1002/jcp. 21284.
61. Gosselin K, Martien S, Pourtier A, Vercamer C, Ostoich P, Morat L, et al. Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells. Cancer Res. 2009;69(20):7917-25, http://dx.doi.org/10.1158/0008-5472. CAN-08-2510.
62. Hajkova P, Ancelin K, Waldmann T, Lacoste N, Lange UC, Cesari F, et al. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature. 2008;452(7189):877-81, http://dx.doi.org/10.1038/nature06714.
63. Chia N, Wang L, Lu X, Senut MC, Brenner C, Ruden DM. Hypothesis: Environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics. 2011;6(7):853-6, http://dx.doi.org/10.4161/epi.6.7.16461.
64. Koturbash I, Zemp FJ, Pogribny I, Kovalchuk O. Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis. Mutat Res. 2011;722(2):94-105, http://dx.doi.org/10.1016/j.mrgentox.2010.05.006.
65. Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci. 2004;1019:278-84, http://dx.doi.org/10.1196/annals.1297.047.
66. Freund A, Orjalo AV, Desprez P-Y, Campisi J. Inflammatory networks during cellular senescence: Causes and consequences. Trends Mol Med. 2010;16(5):238-46, http://dx.doi.org/10.1016/j.molmed.2010.03.003.
67. Mishra PK, Raghuram GV, Jain D, Jain SK, Khare NK, Pathak N. Mitochondrial oxidative stress-induced epigenetic modifications in pancreatic epithelial cells. Int J Toxicol. 2014;33(2):116-29, http://dx.doi.org/10. 1177/1091581814524064.
68. Raghuram GV, Mishra PK. Stress induced premature senescence: A new culprit in ovarian tumorigenesis? Indian J Med Res. 2014;140 Suppl: S120-9.
69. Mishra PK, Bunkar N, Raghuram GV, Khare NK, Pathak N, Bhargava A. Epigenetic dimension of oxygen radical injury in spermatogonial epithelial cells. Reprod Toxicol. 2015;52:40-56, http://dx.doi.org/10.1016/j.reprotox. 2015.02.006.
70. Mishra PK, Dabadghao S, Modi GK, Desikan P, Jain A, Mittra I, et al. In utero exposure to methyl isocyanate in the Bhopal gas disaster: Evidence of persisting hyperactivation of immune system 2 decades later. Occup Environ Med. 2009;66(4):279, http://dx.doi.org/10.1136/oem.2008.041517.
71. Mishra PK, Bhargava A, Pathak N, Desikan P, Maudar KK, Varshney S, et al. Molecular surveillance of hepatitis and tuberculosis infections in a cohort exposed to methyl isocyanate. Int J Occup Med Environ Health. 2011;24(1):94-101, http://dx.doi.org/10.2478/s13382-011-0006-2.
72. Punde RP, Bhargava A, Varshney S, Pathak N, Shrivastava M, Mishra PK. Ascertaining the prevalence of occult hepatitis B virus infection in voluntary blood donors: A study from Central India. Indian J Pathol Microbiol. 2011;54(2):408, http://dx.doi.org/10.4103/0377-4929.81592.
73. Bhargava A, Punde R, Varshney S, Pathak N, Mishra PK. A novel FRET probe-based approach for identification, quantification, and characterization of occult HCV infections in patients with cryptogenic liver cirrhosis. Indian J Pathol Microbiol. 2011;54(2):420-1, http://dx.doi.org/10.4103/0377-4929.81609.
74. Khan S, Bhargava A, Pathak N, Maudar KK, Varshney S, Mishra PK. Circulating biomarkers and their possible role in pathogenesis of chronic hepatitis B and C viral infections. Indian J Clin Biochem. 2011;26(2):161-8, http://dx.doi.org/10.1007/s12291-010-0098-7.
75. Mishra PK, Bhargava A, Khan S, Pathak N, Punde RP, Varshney S. Prevalence of hepatitis C virus genotypes and impact of T helper cytokines in achieving sustained virological response during combination therapy: A study from Central India. Indian J Med Microbiol. 2010;28(4):358-62, http://dx.doi.org/10.4103/0255-0857.71813.
76. Bhargava A, Pathak N, Varshney S, Shrivastava M, Mishra PK. Molecular detection of window phase hepatitis C virus infection in voluntary blood donors and health care workers in a cohort from central India. Indian J Community Med. 2014;39(1):51-2, http://dx.doi.org/10.4103/0970-0218.126362.
77. Bhargava A, Mishra D, Banerjee S, Mishra PK. Dendritic cell engineering for tumor immunotherapy: From biology to clinical translation. Immunotherapy. 2012;4(7):703-18, http://dx.doi.org/10.2217/imt.12.40.
78. Bhargava A, Mishra D, Khan S, Varshney SK, Banerjee S, Mishra PK. Assessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineering. Nanomedicine (Lond). 2013;8(7):1067-84, http://dx.doi.org/10.2217/nnm.12.164.
79. Bhargava A, Mishra D, Banerjee S, Mishra PK. Engineered dendritic cells for gastrointestinal tumor immunotherapy: Opportunities in translational research. J Drug Target. 2013;21(2):126-36, http://dx.doi.org/10.3109/106118 6X.2012.731069.
80. Bhargava A, Bunkar N, Khare NK, Mishra D, Mishra PK. Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: From biology to translational medicine. Nanomedicine (Lond). 2014;9(14):2187-202, http://dx.doi.org/10.2217/nnm.14.115.